LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Clinical trials for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER NON-SMALL CELL CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lung cancers: drug combo targets gene mutations
Disease control Not yet recruitingThis study tests a drug called ivonescimab, alone or with chemotherapy, in people with advanced non-small cell lung cancer that has certain gene changes. The goal is to see if the treatment can shrink tumors and keep the cancer from growing. About 46 adults who have already tried…
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Can volunteer navigators ease the burden of lung cancer?
Symptom relief Not yet recruitingThis study tests a program called Care and Connect, where trained volunteers help lung cancer patients find information, support, and resources. The goal is to see if the program is practical and helpful for reducing stress and improving well-being. About 50 adults with lung canc…
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC